<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK305870" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK305870/" /><meta name="ncbi_pagename" content="Lysosomal Acid Lipase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Lysosomal Acid Lipase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Lysosomal Acid Lipase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/09/01" /><meta name="citation_author" content="Erin P Hoffman" /><meta name="citation_author" content="Marci L Barr" /><meta name="citation_author" content="Monica A Giovanni" /><meta name="citation_author" content="Michael F Murray" /><meta name="citation_pmid" content="26225414" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK305870/" /><meta name="citation_keywords" content="Acid Lipase Deficiency" /><meta name="citation_keywords" content="LAL Deficiency" /><meta name="citation_keywords" content="LAL Deficiency" /><meta name="citation_keywords" content="Acid Lipase Deficiency" /><meta name="citation_keywords" content="Wolman Disease" /><meta name="citation_keywords" content="Cholesterol Ester Storage Disease" /><meta name="citation_keywords" content="Lysosomal acid lipase/cholesteryl ester hydrolase" /><meta name="citation_keywords" content="LIPA" /><meta name="citation_keywords" content="Lysosomal Acid Lipase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Lysosomal Acid Lipase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Erin P Hoffman" /><meta name="DC.Contributor" content="Marci L Barr" /><meta name="DC.Contributor" content="Monica A Giovanni" /><meta name="DC.Contributor" content="Michael F Murray" /><meta name="DC.Date" content="2016/09/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK305870/" /><meta name="description" content="The phenotypic spectrum of lysosomal acid lipase (LAL) deficiency ranges from the infantile-onset form (Wolman disease) to later-onset forms collectively known as cholesterol ester storage disease (CESD)." /><meta name="og:title" content="Lysosomal Acid Lipase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="The phenotypic spectrum of lysosomal acid lipase (LAL) deficiency ranges from the infantile-onset form (Wolman disease) to later-onset forms collectively known as cholesterol ester storage disease (CESD)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK305870/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/lal-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK305870/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B30BEE03F7C2100000000080902C2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK305870_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK305870_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lpi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ftdp-17/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK305870_"><span class="title" itemprop="name">Lysosomal Acid Lipase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Acid Lipase Deficiency, LAL Deficiency</div><p class="contrib-group"><span itemprop="author">Erin P Hoffman</span>, MS, CGC, <span itemprop="author">Marci L Barr</span>, ScM, <span itemprop="author">Monica A Giovanni</span>, MS, CGC, and <span itemprop="author">Michael F Murray</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK305870_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK305870_ai__"><div class="contrib half_rhythm"><span itemprop="author">Erin P Hoffman</span>, MS, CGC<div class="affiliation small">Littleton Adventist Hospital<br />Littleton, Colorado<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.arutnec@namffohnire" class="oemail">gro.arutnec@namffohnire</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marci L Barr</span>, ScM<div class="affiliation small">Genomic Medicine Institute<br />Geisinger Health System<br />Danville, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.regnisieg@1rrabm" class="oemail">ude.regnisieg@1rrabm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Monica A Giovanni</span>, MS, CGC<div class="affiliation small">Genomic Medicine Institute<br />Geisinger Health System<br />Danville, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.regnisieg@innavoigam" class="oemail">ude.regnisieg@innavoigam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Michael F Murray</span>, MD<div class="affiliation small">Director of Clinical Genomics<br />Genomic Medicine Institute<br />Geisinger Health System<br />Danville, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.regnisieg@1yarrumfm" class="oemail">ude.regnisieg@1yarrumfm</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 30, 2015</span>; Last Revision: <span itemprop="dateModified">September 1, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="lal-def.Summary" itemprop="description"><h2 id="_lal-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The phenotypic spectrum of lysosomal acid lipase (LAL) deficiency ranges from the infantile-onset form (Wolman disease) to later-onset forms collectively known as cholesterol ester storage disease (CESD).</p><p><i>Wolman disease</i> is characterized by infantile-onset malabsorption that results in malnutrition, storage of cholesterol esters and triglycerides in hepatic macrophages that results in hepatomegaly and liver disease, and adrenal gland calcification that results in adrenal cortical insufficiency. Unless successfully treated with hematopoietic stem cell transplantation (HSCT), infants with classic Wolman disease do not survive beyond age one year.</p><p><i>CESD</i> may present in childhood in a manner similar to Wolman disease or later in life with such findings as serum lipid abnormalities, hepatosplenomegaly, and/or elevated liver enzymes long before a diagnosis is made. The morbidity of late-onset CESD results from atherosclerosis (coronary artery disease, stroke), liver disease (e.g., altered liver function &#x000b1; jaundice, steatosis, fibrosis, cirrhosis and related complications of esophageal varices, and/or liver failure), complications of secondary hypersplenism (i.e., anemia and/or thrombocytopenia), and/or malabsorption. Individuals with CESD may have a normal life span depending on the severity of disease manifestations.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis of LAL deficiency is suspected in individuals with characteristic clinical findings such as hepatomegaly, elevated transaminases, and a typical serum lipid profile: high total serum concentrations of cholesterol, low-density lipoprotein, and triglycerides; and low serum concentration of high-density lipoprotein. The diagnosis is confirmed by identification of either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>LIPA</i> or deficient LAL enzyme activity in peripheral blood leukocytes, fibroblasts, or dried blood spots.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><ul><li class="half_rhythm"><div>Both Wolman disease and CESD: Enzyme replacement therapy (ERT) with sebelipase alfa was recently approved by the FDA and is administered at a dose of 1 mg/kg body weight every other week; this treatment can be life saving for those with severe Wolman syndrome and life improving with prolonged survival in those who have CESD. Consider referral to a liver specialist. Liver transplantation may be indicated when liver disease progresses to cirrhosis and liver failure.</div></li><li class="half_rhythm"><div>Wolman disease: Consultation with a nutrition team to limit malnutrition if possible, including use of parenteral nutrition; corticosteroid and mineralocorticoid replacement in the presence of adrenal insufficiency.</div></li><li class="half_rhythm"><div>CESD: Reduce cholesterol through the use of statins, cholestyramine, and a diet low in cholesterol and triglycerides. Aggressive reduction of additional cardiovascular risk factors and lipophilic vitamins may also be beneficial. Consult with a nutrition team for children with failure to thrive or adults with weight loss.</div></li></ul><p><i>Prevention of primary manifestations:</i> Successful hematopoietic stem cell transplantation can correct the metabolic defect.</p><p><i>Prevention of secondary complications:</i> Use nonspecific beta-blockers in those with esophageal varices to reduce the risk of bleeding.</p><p><i>Surveillance:</i> No standard guidelines for surveillance of CESD have been developed.</p><ul><li class="half_rhythm"><div>For children: Monitor growth and nutritional status; evaluate fasting lipid levels, platelet count, and liver enzymes every six months.</div></li><li class="half_rhythm"><div>For adults: reevaluate every 6-12 months depending on disease severity. Monitor nutritional status. Evaluate fasting lipid levels, platelet count, and liver enzymes routinely. Evaluate those with severe liver disease for esophageal varices by upper endoscopy every three years. Monitor and treat those with hepatosplenomegaly thrombocytopenia to prevent bleeding complications.</div></li><li class="half_rhythm"><div>For children and adults: monitor hepatosplenic volume and screen for hepatocellular carcinoma with serial liver and spleen imaging.</div></li></ul><p><i>Agents/circumstances to avoid:</i> In the presence of thrombocytopenia avoid use of nonsteroidal anti-inflammatory drugs.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to evaluate the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify those who would benefit from early treatment and surveillance.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>LAL deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> of pregnancies at increased risk are possible if the <i>LIPA</i> pathogenic variants in the family have been identified.</p></div></div><div id="lal-def.GeneReview_Scope"><h2 id="_lal-def_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="lal-def.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK305870/table/lal-def.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lal-def.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lal-def.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lysosomal Acid Lipase Deficiency: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_lal-def.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cholesterol ester storage disease</div></li><li class="half_rhythm"><div>Wolman disease</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#lal-def.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="lal-def.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#lal-def.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="lal-def.Diagnosis"><h2 id="_lal-def_Diagnosis_">Diagnosis</h2><p>The phenotypic spectrum of lysosomal acid lipase (LAL) deficiency ranges from infantile-onset form (Wolman disease) to later-onset forms, collectively known as cholesterol ester storage disease (CESD). LAL deficiency cannot be diagnosed on clinical findings alone.</p><div id="lal-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p><b>Wolman disease</b>
<b>is suspected</b> in infants with hepatomegaly, vomiting, diarrhea, and failure to thrive. Adrenal calcification on abdominal imaging greatly increases suspicion for Wolman disease [<a class="bk_pop" href="#lal-def.REF.anderson.1999.333">Anderson et al 1999</a>, <a class="bk_pop" href="#lal-def.REF.boldrini.2004.231">Boldrini et al 2004</a>].</p><p><b>Cholesterol ester storage disease (CESD)</b>
<b>is suspected</b> in individuals (ranging in age from early childhood to adulthood) with signs of increased lipid storage such as hepatomegaly, liver disease, lipid deposition in the intestinal walls, and/or xanthelasma.</p><div id="lal-def.Preliminary_Testing"><h4>Preliminary Testing</h4><p>Serum concentrations of lipids and lipoproteins are almost always abnormal (<a class="figpopup" href="/books/NBK305870/table/lal-def.T.lipid_values_found_in_33_indiv/?report=objectonly" target="object" rid-figpopup="figlaldefTlipidvaluesfoundin33indiv" rid-ob="figoblaldefTlipidvaluesfoundin33indiv">Table 1</a>).</p><ul><li class="half_rhythm"><div>Total serum concentration of cholesterol is often high, as are serum concentrations of low-density lipoprotein (LDL) and triglycerides.</div></li><li class="half_rhythm"><div>Serum concentration of high-density lipoprotein (HDL) is typically low.</div></li></ul><p>Note: Normal serum lipid levels do not exclude the diagnosis of LAL deficiency [<a class="bk_pop" href="#lal-def.REF.drebber.2005.2364">Drebber et al 2005</a>, <a class="bk_pop" href="#lal-def.REF.chatrath.2009.168">Chatrath et al 2009</a>, <a class="bk_pop" href="#lal-def.REF.decarlis.2009.s11">Decarlis et al 2009</a>, <a class="bk_pop" href="#lal-def.REF.pisciotta.2009.143">Pisciotta et al 2009</a>].</p><div id="lal-def.T.lipid_values_found_in_33_indiv" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Lipid Values Found in 33 Individuals with LAL Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK305870/table/lal-def.T.lipid_values_found_in_33_indiv/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lal-def.T.lipid_values_found_in_33_indiv_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Cholesterol&#x000a0;<sup>1</sup></th><th id="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_3" style="text-align:left;vertical-align:middle;">Triglycerides&#x000a0;<sup>2</sup></th></tr><tr><th headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2" id="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Total</th><th headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2" id="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LDL</th><th headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2" id="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">HDL</th></tr></thead><tbody><tr><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Normal</b></td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;200</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;130</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;50</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;150</td></tr><tr><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>In reported cases</b></td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Range</b></td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">106-428</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">147-292</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8-87</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60-443</td></tr><tr><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Average</b></td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">291</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">228</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">200</td></tr><tr><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>% of cases &#x0003e; or &#x0003c; normal range</b></td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">88% &#x0003e; nml</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% &#x0003e; nml</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_2 hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96% &#x0003c; nml</td><td headers="hd_h_lal-def.T.lipid_values_found_in_33_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">71% &#x0003e; nml</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#lal-def.REF.elleder.1990">Elleder et al [1990]</a>, <a class="bk_pop" href="#lal-def.REF.klima.1993.2713">Klima et al [1993]</a>, <a class="bk_pop" href="#lal-def.REF.seedorf.1995.773">Seedorf et al [1995]</a>, <a class="bk_pop" href="#lal-def.REF.gasche.1997.744">Gasche et al [1997]</a>, <a class="bk_pop" href="#lal-def.REF.anderson.1999.333">Anderson et al [1999]</a>, <a class="bk_pop" href="#lal-def.REF.vom_dahl.1999.741">vom Dahl et al [1999]</a>, <a class="bk_pop" href="#lal-def.REF.lohse.2000.23">Lohse et al [2000]</a>, <a class="bk_pop" href="#lal-def.REF.tadiboyina.2005.26">Tadiboyina et al [2005]</a>, <a class="bk_pop" href="#lal-def.REF.dalgi_.2006.148">Dalgi&#x000e7; et al [2006]</a>, <a class="bk_pop" href="#lal-def.REF.bindu.2007.1401">Bindu et al [2007]</a>, <a class="bk_pop" href="#lal-def.REF.chatrath.2009.168">Chatrath et al [2009]</a>, <a class="bk_pop" href="#lal-def.REF.hooper.2008.152">Hooper et al [2008]</a>, <a class="bk_pop" href="#lal-def.REF.decarlis.2009.s11">Decarlis et al [2009]</a>, <a class="bk_pop" href="#lal-def.REF.pisciotta.2009.143">Pisciotta et al [2009]</a>, <a class="bk_pop" href="#lal-def.REF.fasano.2012.450">Fasano et al [2012]</a></p></div></dd><dt>1. </dt><dd><div id="lal-def.TF.1.1"><p class="no_margin">Values in mg/dL</p></div></dd></dl></div></div></div></div></div><div id="lal-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis <b>is confirmed</b> by identification of either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>LIPA</i> or deficient LAL enzyme activity in peripheral blood leukocytes, fibroblasts, or dried blood spots.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>LIPA</i> is performed first. Consider gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>LIPA</i> and other genes of interest (see <a href="#lal-def.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of lysosomal acid lipase deficiency. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="lal-def.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Lysosomal Acid Lipase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK305870/table/lal-def.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lal-def.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">One Variant Detected</th><th headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3" id="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Two Variants Detected</th></tr></thead><tbody><tr><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>LIPA</i></td><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_1 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_2" colspan="2" rowspan="1" style="text-align:center;vertical-align:middle;"><b>Wolman disease</b></td></tr><tr><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1/7 probands</td><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/7 probands</td></tr><tr><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_1 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_2" colspan="2" scope="col" rowspan="1" style="text-align:center;vertical-align:middle;"><b>CESD</b></td></tr><tr><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2/31 probands</td><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">29/31 probands</td></tr><tr><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td><td headers="hd_h_lal-def.T.molecular_genetic_testing_used_1_1_1_3 hd_h_lal-def.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lal-def.TF.2.1"><p class="no_margin">See <a href="/books/NBK305870/#lal-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="lal-def.TF.2.2"><p class="no_margin">See <a href="#lal-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="lal-def.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#lal-def.REF.klima.1993.2713">Klima et al [1993]</a>, <a class="bk_pop" href="#lal-def.REF.ameis.1995.241">Ameis et al [1995]</a>, <a class="bk_pop" href="#lal-def.REF.muntoni.1995.491">Muntoni et al [1995]</a>, <a class="bk_pop" href="#lal-def.REF.seedorf.1995.773">Seedorf et al [1995]</a>, <a class="bk_pop" href="#lal-def.REF.gasche.1997.744">Gasche et al [1997]</a>, <a class="bk_pop" href="#lal-def.REF.anderson.1999.333">Anderson et al [1999]</a>, <a class="bk_pop" href="#lal-def.REF.vom_dahl.1999.741">vom Dahl et al [1999]</a>, <a class="bk_pop" href="#lal-def.REF.lohse.2000.23">Lohse et al [2000]</a>, <a class="bk_pop" href="#lal-def.REF.drebber.2005.2364">Drebber et al [2005]</a>, <a class="bk_pop" href="#lal-def.REF.tadiboyina.2005.26">Tadiboyina et al [2005]</a>, <a class="bk_pop" href="#lal-def.REF.hooper.2008.152">Hooper et al [2008]</a>, <a class="bk_pop" href="#lal-def.REF.pisciotta.2009.143">Pisciotta et al [2009]</a>, <a class="bk_pop" href="#lal-def.REF.lee.2011.703">Lee et al [2011]</a>, <a class="bk_pop" href="#lal-def.REF.fasano.2012.450">Fasano et al [2012]</a></p></div></dd><dt>4. </dt><dd><div id="lal-def.TF.2.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="lal-def.TF.2.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="lal-def.TF.2.6"><p class="no_margin">Large deletions appear to be rare, but have been reported [<a class="bk_pop" href="#lal-def.REF.lee.2011.703">Lee et al 2011</a>].</p></div></dd><dt>7. </dt><dd><div id="lal-def.TF.2.7"><p class="no_margin">Examples of homozygosity for <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions have not been reported.</p></div></dd></dl></div></div></div><p><b>Assay of lysosomal acid lipase (LAL) enzyme activity.</b> Residual enzyme activity levels are more significantly decreased in Wolman syndrome (&#x02264;5% of controls) compared to a generally less severe but overlapping range of loss of activity in CESD (range 2%-11% of residual activity) [<a class="bk_pop" href="#lal-def.REF.fasano.2012.450">Fasano et al 2012</a>].</p><p>Note: (1) Assay of LAL enzyme activity in peripheral blood leukocytes is the confirmatory diagnostic test for LAL deficiency; however, enzyme activity can also be diagnostically measured in hepatocytes, skin fibroblasts, or dried blood spots that have been promptly transported and properly stored [<a class="bk_pop" href="#lal-def.REF.reiner.2014.21">Reiner et al 2014</a>]. (2) The confirmation of significant loss of LAL enzymatic function is recommended when <i>LIPA</i> pathogenic variants identified on genome-wide sequencing (e.g., <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>) first suggest the diagnosis of LAL deficiency.</p><p><b>Liver biopsy.</b> Note: Use of more invasive testing, such as liver biopsy, is not necessary in the diagnostic evaluation of all persons suspected of having LAL deficiency. See Clinical Description, <a href="#lal-def.Liver_Biopsy">Liver Biopsy</a>.</p></div></div><div id="lal-def.Clinical_Characteristics"><h2 id="_lal-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="lal-def.Clinical_Description"><h3>Clinical Description</h3><p>Lysosomal acid lipase (LAL) deficiency, like other diseases caused by enzyme deficiencies, has a wide phenotypic spectrum. Infantile-onset LAL deficiency is known as Wolman disease. All later-onset LAL deficiency, which may present from early childhood to late adulthood (often with subclinical disease), is known as cholesterol ester storage disease (CESD).</p><div id="lal-def.Wolman_Disease"><h4>Wolman Disease</h4><p>Infants with Wolman disease may present as early as the first day of life with vomiting, steatorrhea, and abdominal distention [<a class="bk_pop" href="#lal-def.REF.shome.2002.597">Shome et al 2002</a>]. Other infants may come to medical attention within weeks to months due to failure to thrive [<a class="bk_pop" href="#lal-def.REF.browne.2003.522">Browne et al 2003</a>].</p><p>Hepatomegaly, the result of build-up of cholesterol esters and triglycerides in macrophages of the liver, is common and can be dramatic. Splenomegaly, the result of the same mechanism, may also be present.</p><p>Increased lipid deposition along the gastrointestinal tract leads to thickened bowel walls with resultant malnutrition and wasting [<a class="bk_pop" href="#lal-def.REF.nchimi.2003.284">Nchimi et al 2003</a>].</p><p>Steatosis may progress to liver failure.</p><p>Enlarged adrenal glands with calcification, a classic finding in Wolman disease, can lead to adrenal cortical insufficiency.</p><p>Infants with Wolman disease do not usually survive beyond the first year of life. Treatment with hematopoietic stem cell transplantation (HSCT) has had mixed results, and requires further study [<a class="bk_pop" href="#lal-def.REF.gramatges.2009.449">Gramatges et al 2009</a>]. Death results from a combination of malnutrition, liver disease, and adrenal cortical insufficiency.</p></div><div id="lal-def.Cholesterol_Ester_Storage_Diseas"><h4>Cholesterol Ester Storage Disease (CESD)</h4><p>Although CESD may present in childhood in a manner similar to Wolman disease with failure to thrive and delayed milestones [<a class="bk_pop" href="#lal-def.REF.bindu.2007.1401">Bindu et al 2007</a>], it has also been identified in individuals with atypical phenotypes such as elevated liver enzymes or serum lipid abnormalities identified on routine screening [<a class="bk_pop" href="#lal-def.REF.drebber.2005.2364">Drebber et al 2005</a>] and apparent <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hypercholesterolemia without mutation of the expected <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#lal-def.REF.stitziel.2013.2909">Stitziel et al 2013</a>] (see <a href="#lal-def.Differential_Diagnosis">Differential Diagnosis</a>, <b>Autosomal recessive hypercholesterolemia</b>).</p><p>Atherosclerosis due to hyperlipidemia accounts for much of the morbidity associated with late-onset CESD, such as coronary artery disease and catastrophic vascular events including stroke [<a class="bk_pop" href="#lal-def.REF.elleder.1990">Elleder et al 1990</a>]. In one family the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resembled <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hypercholesterolemia (see <a href="#lal-def.Differential_Diagnosis">Differential Diagnosis</a>) with extremely high total and low-density lipoprotein cholesterol levels, and abnormal hepatic accumulation of cholesterol without other features of CESD [<a class="bk_pop" href="#lal-def.REF.stitziel.2013.2909">Stitziel et al 2013</a>].</p><p>Hepatomegaly with or without splenomegaly is frequently present as a result of cholesterol ester and triglyceride build-up in macrophages. Organomegaly, often among the first findings noted, may be present for years before a diagnosis is reached [<a class="bk_pop" href="#lal-def.REF.ameis.1995.241">Ameis et al 1995</a>, <a class="bk_pop" href="#lal-def.REF.vom_dahl.1999.741">vom Dahl et al 1999</a>]. Individuals with splenomegaly may develop anemia and/or thrombocytopenia due to secondary hypersplenism.</p><p>Liver disease is common. It may present as altered liver function with or without jaundice, steatosis, fibrosis, or cirrhosis. Liver disease can lead to esophageal varices, which are associated with risk for hemorrhage and can be life-threatening [<a class="bk_pop" href="#lal-def.REF.gasche.1997.744">Gasche et al 1997</a>]. Some individuals may experience liver failure.</p><p>Hepatocellular carcinoma has occurred in the setting of advanced cirrhosis [<a class="bk_pop" href="#lal-def.REF.riva.2008.784">Riva et al 2008</a>].</p><p>Lipid deposition in the wall of the intestinal tract can contribute to diarrhea and weight loss [<a class="bk_pop" href="#lal-def.REF.anderson.1999.333">Anderson et al 1999</a>, <a class="bk_pop" href="#lal-def.REF.drebber.2005.2364">Drebber et al 2005</a>].</p><p>On occasion, signs of hyperlipidemia (e.g., xanthelasma, particularly of the palpebral area) may be visible [<a class="bk_pop" href="#lal-def.REF.elleder.1990">Elleder et al 1990</a>, <a class="bk_pop" href="#lal-def.REF.vom_dahl.1999.741">vom Dahl et al 1999</a>].</p><p>Enlarged adrenal glands with punctate calcifications can be present, more often in those with more severe disease [<a class="bk_pop" href="#lal-def.REF.boldrini.2004.231">Boldrini et al 2004</a>].</p><p>Individuals with CESD may have a normal life span depending on the severity of disease manifestations.</p></div><div id="lal-def.Liver_Biopsy"><h4>Liver Biopsy</h4><p>Liver biopsy demonstrates microvesicular steatosis or "fatty liver." To help distinguish LAL deficiency (both Wolman and CESD) from common diagnoses with overlapping findings (see <a href="#lal-def.Differential_Diagnosis">Differential Diagnosis</a>), the following findings on liver biopsy are used:</p><ul><li class="half_rhythm"><div>Presence of additional supportive findings including "sea-blue" histiocytes, large Kupffer cells with increased vacuoles, lipid droplets, and/or cholesterol crystals [<a class="bk_pop" href="#lal-def.REF.boldrini.2004.231">Boldrini et al 2004</a>, <a class="bk_pop" href="#lal-def.REF.drebber.2005.2364">Drebber et al 2005</a>, <a class="bk_pop" href="#lal-def.REF.pisciotta.2009.143">Pisciotta et al 2009</a>]</div></li><li class="half_rhythm"><div>Immunohistochemistry including use of the lysosomal markers cathepsin D, lysosomal-associated membrane protein 1 (LAMP1), LAMP2, and lysosomal integral membrane protein 2 [<a class="bk_pop" href="#lal-def.REF.h_lkov_.2012.1107">H&#x0016f;lkov&#x000e1; &#x00026; Elleder 2012</a>]</div></li><li class="half_rhythm"><div>Identification of Maltese cross-type birefringence in frozen sections [<a class="bk_pop" href="#lal-def.REF.h_lkov_.2012.1107">H&#x0016f;lkov&#x000e1; &#x00026; Elleder 2012</a>]</div></li></ul></div></div><div id="lal-def.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In general, <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> allelic variants with no residual enzyme function result in Wolman disease and pathogenic variants that allow for residual LAL enzyme activity result in CESD.</p><p>The <a class="figpopup" href="/books/NBK305870/table/lal-def.T.selected_lipa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figlaldefTselectedlipapathogenicvaria" rid-ob="figoblaldefTselectedlipapathogenicvaria">c.894G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, associated with residual enzyme activity, has been identified in European and Hispanic populations and, to a lesser extent, in Asian populations. Although this variant has not been identified in African Americans, it cannot be concluded that this population is not at risk for this condition [<a class="bk_pop" href="#lal-def.REF.scott.2013.958">Scott et al 2013</a>]. Variant c.894G&#x0003e;A is the most common observed in CESD, accounting for more than 50% of reported pathogenic variants [<a class="bk_pop" href="#lal-def.REF.bernstein.2013.1230">Bernstein et al 2013</a>]. Nearly all individuals with CESD reported in the published literature are <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for c.894G&#x0003e;A. Of note, three members of one family homozygous for the c.894G&#x0003e;A variant had an atypical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that resembled <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hypercholesterolemia (see <a href="#lal-def.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#lal-def.REF.stitziel.2013.2909">Stitziel et al 2013</a>].</p><p>Among individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>, varying levels of residual enzyme activity have been reported; therefore, the predictive value of genotype is only in distinguishing Wolman disease from CESD.</p><p>The level of residual LAL enzyme activity identified on enzyme assay is not useful for predicting disease course, as manifestations of disease vary greatly among individuals with similar levels of enzyme activity.</p></div><div id="lal-def.Nomenclature"><h3>Nomenclature</h3><p>Other names used for lysosomal acid lipase (LAL) deficiency in the past that are no longer in use include:</p><ul><li class="half_rhythm"><div>Acid cholesterol ester hydrolase deficiency</div></li><li class="half_rhythm"><div>Cholesterol ester hydrolase deficiency storage disease</div></li></ul><p>Cholesterol ester storage disease is also known as cholesteryl ester storage disease.</p></div><div id="lal-def.Prevalence"><h3>Prevalence</h3><p>Due to the rarity and under-recognition of LAL deficiency, precise prevalence rates are not known at this time. Estimates in a German cohort suggested 1:50,000 for CESD and 1:350,000 for Wolman disease; however, LAL deficiency may be found to be more common as milder phenotypes continue to be recognized [<a class="bk_pop" href="#lal-def.REF.muntoni.2007.1866">Muntoni et al 2007</a>].</p><p>LAL deficiency may be more common in individuals of Iranian-Jewish ancestry: one study suggested rates as high as 1:4200 in the Iranian-Jewish population of the Los Angeles area due to a <a class="figpopup" href="/books/NBK305870/table/lal-def.T.selected_lipa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figlaldefTselectedlipapathogenicvaria" rid-ob="figoblaldefTselectedlipapathogenicvaria">c.260G&#x0003e;T</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#lal-def.REF.vallesayoub.2011.395">Valles-Ayoub et al 2011</a>]<i>.</i> This <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported both in individuals with Wolman disease and in those with CESD [<a class="bk_pop" href="#lal-def.REF.vallesayoub.2011.395">Valles-Ayoub et al 2011</a>, <a class="bk_pop" href="#lal-def.REF.pagani.1996.1611">Pagani et al 1996</a>].</p></div></div><div id="lal-def.Genetically_Related_Allelic_Diso"><h2 id="_lal-def_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those described in this <i>GeneReview</i> are known to be associated with mutation of <i>LIPA.</i></p></div><div id="lal-def.Differential_Diagnosis"><h2 id="_lal-def_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/npab/"><b>Acid sphingomyelinase deficiency</b></a>
<b>(Niemann-Pick disease, types A and B).</b> Overlapping clinical features of lysosomal acid lipase (LAL) deficiency and Niemann-Pick disease types A and B are hepatosplenomegaly, which is common in both, and lipid profiles in Niemann-Pick disease A and B which may be similar to those in LAL deficiency (i.e., low HDL with hyperlipidemia).</p><p>In contrast, the interstitial lung disease and ophthalmologic findings common to Niemann-Pick disease are not observed in LAL deficiency.</p><p>Biochemical analysis distinguishes between the two disorders [<a class="bk_pop" href="#lal-def.REF.vom_dahl.1999.741">vom Dahl et al 1999</a>]. Mutation of <i>SMPD1</i> is causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/gaucher/"><b>Gaucher disease</b></a>
<b>(GD).</b> Overlapping clinical features of lysosomal acid lipase (LAL) deficiency and GD are hepatosplenomegaly and thrombocytopenia.</p><p>In contrast, the adrenal calcifications typical of Wolman disease (and occasionally CESD) and the abnormal lipid profile typical of LAL deficiency are not seen in GD. The bone manifestations common to GD type 1 are not observed in CESD.</p><p>Biochemical analysis can distinguish between the two diseases [<a class="bk_pop" href="#lal-def.REF.vom_dahl.1999.741">vom Dahl et al 1999</a>]. Mutation of <i>GBA</i> is causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><a href="/books/n/gene/hyperchol/"><b>Familial hypercholesterolemia</b></a><b>.</b> CESD may initially be confused with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hypercholesterolemia because of increased serum concentration of total cholesterol and LDL; however, serum concentrations of HDL and triglycerides are usually still in the normal range. Liver disease and organomegaly are not observed in familial hypercholesterolemia. Mutation of <i>LDLR</i>, <i>APOB</i>, or <i>PCSK9</i> accounts for 60%-80% of familial hypercholesterolemia. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Autosomal recessive hypercholesterolemia (ARH)</b> (OMIM <a href="http://omim.org/entry/603813" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">603813</a>). CESD manifesting as extremely high total and low-density lipoprotein cholesterol levels may resemble ARH [<a class="bk_pop" href="#lal-def.REF.stitziel.2013.2909">Stitziel et al 2013</a>]. Mutation of <i>LDLRAP1</i> is causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</p><p><b>Hepatosplenomegaly</b> is common to many storage disorders, including other lysosomal storage disorders. Other storage disorders can often be distinguished from LAL deficiency based on associated features:</p><ul><li class="half_rhythm"><div>Contractures, skeletal dysplasia, and coarse features which can be found in <a href="/books/n/gene/ml2/">mucolipidosis II</a> and the mucopolysaccharidoses (<a href="/books/n/gene/mps1/">MPS I</a>, <a href="/books/n/gene/hunter/">MPS II</a>, <a href="/books/n/gene/mps4a/">MPS IVA</a>, <a href="/books/n/gene/gm1-ganglio/">MPS IVB</a>) are absent in LAL deficiency.</div></li><li class="half_rhythm"><div>Hypoglycemia, kidney disease, and cardiomyopathy, which can be seen in the glycogen storage diseases (<a href="/books/n/gene/gsd1/">GSD I</a>, <a href="/books/n/gene/gsd2/">GSD II</a>, <a href="/books/n/gene/gsd3/">GSD III</a>, <a href="/books/n/gene/gsd4/">GSD IV</a>, <a href="/books/n/gene/gsd5/">GSD V</a>, <a href="/books/n/gene/gsd6/">GSD VI</a>), are absent in LAL deficiency.</div></li></ul><p>Biochemical analysis can distinguish between storage disorders.</p><p><b>Liver disease</b> in CESD is commonly misattributed to hepatitis, non-alcoholic fatty liver disease, or cryptogenic cirrhosis. Nonalcoholic fatty liver disease, which is associated with obesity, is a common finding on liver biopsy; therefore, body mass index should be considered along with other signs and symptoms when considering the cause of "fatty liver" disease.</p></div><div id="lal-def.Management"><h2 id="_lal-def_Management_">Management</h2><div id="lal-def.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with lysosomal acid lipase (LAL) deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete blood count</div></li><li class="half_rhythm"><div>Complete fasting lipid profile, if not done at the time of diagnosis</div></li><li class="half_rhythm"><div>Liver function tests</div></li><li class="half_rhythm"><div>Upper endoscopy to evaluate individuals with severe liver disease for the presence of esophageal varices</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="lal-def.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Enzyme replacement therapy (ERT) with sebelipase alfa was approved by the FDA in late 2015.</p><ul><li class="half_rhythm"><div>Results from a Phase III clinical trial of 66 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals demonstrated that ERT can be life saving for those with severe Wolman syndrome and life improving with prolonged survival in those who have cholesterol ester storage disease [<a class="bk_pop" href="#lal-def.REF.burton.2015.1010">Burton et al 2015</a>].</div></li><li class="half_rhythm"><div>ERT is administered intravenously at a dose of 1 mg/kg body weight every other week.</div></li></ul><div id="lal-def.Wolman_Disease_1"><h4>Wolman Disease</h4><p>Symptoms should generally be treated in a routine manner, while keeping in mind the limited life expectancy of infants with untreated Wolman disease.</p><p><b>Malabsorption and malnutrition.</b> Consultation with a nutrition team should be provided in an attempt to limit malnutrition to the extent possible. Parenteral nutrition is offered in many instances of intractable malabsorption.</p><p><b>Hepatomegaly and liver disease.</b> Liver transplantation can be considered for individuals who progress to cirrhosis and liver failure.</p><p><b>Adrenal cortical insufficiency.</b> Corticosteroid and mineralocorticoid replacement is indicated in the presence of insufficiency.</p><p><b>Hematopoietic stem cell transplantation</b> (HSCT) has overall had mixed results, and requires further study [<a class="bk_pop" href="#lal-def.REF.gramatges.2009.449">Gramatges et al 2009</a>]. While successful engraftment can correct the metabolic defect [<a class="bk_pop" href="#lal-def.REF.stein.2007.663">Stein et al 2007</a>, <a class="bk_pop" href="#lal-def.REF.tolar.2009.21">Tolar et al 2009</a>], HSCT can be associated with morbidity and mortality [<a class="bk_pop" href="#lal-def.REF.yanir.2013.224">Yanir et al 2013</a>].</p><p>Consider discussion of comfort care options.</p></div><div id="lal-def.CESD"><h4>CESD</h4><p><b>Hyperlipidemia.</b> Attempts should be made to reduce cholesterol through the use of statins, cholestyramine, ezetimibe, and a diet low in cholesterol and triglycerides [<a class="bk_pop" href="#lal-def.REF.gasche.1997.744">Gasche et al 1997</a>, <a class="bk_pop" href="#lal-def.REF.dalgi_.2006.148">Dalgi&#x000e7; et al 2006</a>, <a class="bk_pop" href="#lal-def.REF.chatrath.2009.168">Chatrath et al 2009</a>, <a class="bk_pop" href="#lal-def.REF.abello.2010.28">Abello et al 2010</a>].</p><p>Lipophilic vitamin supplementation may also be beneficial.</p><p>Aggressive reduction of additional cardiovascular disease risk factors should be encouraged.</p><p><b>Nutrition.</b> Consultation with a nutrition team should be provided to children experiencing failure to thrive and to adults experiencing weight loss. Additionally, a nutrition team can assist individuals in the implementation of a diet low in cholesterol and triglycerides.</p><p><b>Liver transplantation</b> can be considered for individuals who progress to cirrhosis and liver failure. At least four case reports of successful liver transplantation for CESD have been reported, with post-operative improvement of lipid profiles and successful transplant out to five years in one individual [<a class="bk_pop" href="#lal-def.REF.ambler.2013.41">Ambler et al 2013</a>].</p></div></div><div id="lal-def.Prevention_of_Secondary_Complica"><h3>Prevention of Secondary Complications</h3><p>Individuals found to have esophageal varices should be placed on nonspecific beta-blockers to reduce the risk of bleeding; beta-blockers have not been shown to prevent the formation of esophageal varices.</p></div><div id="lal-def.Surveillance"><h3>Surveillance</h3><p>No standard guidelines for the surveillance of individuals with LAL deficiency have been developed. The following screening practices can be considered to monitor for the most common symptoms associated with CESD.</p><p><b>Children</b></p><ul><li class="half_rhythm"><div>Special attention should be paid to growth and nutritional status. Chronic diarrhea or failure to thrive could indicate malabsorption.</div></li><li class="half_rhythm"><div>Consider monitoring fasting lipid levels, platelet count, and liver enzymes every six months.</div></li></ul><p><b>Adults</b> with CESD should be evaluated every six to 12 months depending on disease severity.</p><ul><li class="half_rhythm"><div>Special attention should be paid to nutritional status. Chronic diarrhea or weight loss could indicate malabsorption.</div></li><li class="half_rhythm"><div>Monitor routinely fasting lipid levels, platelet count, and liver enzymes.</div></li><li class="half_rhythm"><div>Individuals with severe liver disease should be evaluated for esophageal varices by upper endoscopy every three years.</div></li><li class="half_rhythm"><div>Individuals with hepatosplenomegaly should be monitored and treated for thrombocytopenia to prevent bleeding complications.</div></li></ul><p><b>Both children and adults.</b> Obtain serial liver and spleen imaging to monitor for hepatosplenic volume and to screen for hepatocellular carcinoma which has arisen in the setting of advanced cirrhosis [<a class="bk_pop" href="#lal-def.REF.riva.2008.784">Riva et al 2008</a>]. Consensus on optimal screening protocols has not been published.</p></div><div id="lal-def.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Those with thrombocytopenia should avoid use of nonsteroidal anti-inflammatory drugs.</p></div><div id="lal-def.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in order to identify those who would benefit from early institution of treatment.</p><ul><li class="half_rhythm"><div>If the <i>LIPA</i> pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk sibs.</div></li><li class="half_rhythm"><div>If the <i>LIPA</i> pathogenic variants in the family are not known, assay of lysosomal acid lipase (LAL) enzyme activity can be used to assist in the identification of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs.</div></li></ul><p>See <a href="#lal-def.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="lal-def.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Clinical trials are underway for enzyme replacement therapy [<a class="bk_pop" href="#lal-def.REF.valayannopoulos.2014.1135">Valayannopoulos et al 2014</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="lal-def.Genetic_Counseling"><h2 id="_lal-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="lal-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Lysosomal acid lipase (LAL) deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="lal-def.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>LIPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes(carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with lysosomal acid lipase deficiency are obligate heterozygotes (carriers of a <i>LIPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>The risk that offspring will inherit a second <i>LIPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> depends on the reproductive partner's <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status. <i>LIPA</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be offered to the reproductive partner of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual to determine carrier status.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>LIPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="lal-def.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>LIPA</i> pathogenic variants in the family.</p><p>Note: Because of the overlap of lysosomal acid lipase (LAL) enzymatic activity between carriers and non-carriers, assay of LAL enzyme activity is not an appropriate method to determine <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status.</p></div><div id="lal-def.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#lal-def.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="lal-def.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>LIPA</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="lal-def.Resources"><h2 id="_lal-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Lysosomal%20acid%20lipase%20deficiency&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lysosomal acid lipase deficiency</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Acid-Lipase-Disease-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Acid Lipase Disease Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/cholesteryl-ester-storage-disease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cholesteryl Ester Storage Disease</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/wolman-disease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Wolman Disease</a></div></li><li class="half_rhythm"><div><b>Children's Liver Disease Foundation (CLDF)</b></div><div>36 Great Charles Street</div><div> Birmingham B3 3JY</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 121 212 3839</div><div><b>Fax:</b> +44 (0) 121 212 4300</div><div><b>Email:</b> info@childliverdisease.org</div><div><a href="http://www.childliverdisease.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.childliverdisease.org</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li><li class="half_rhythm"><div><b>National Organization for Rare Disorders (NORD)</b></div><div>RareCareSM</div><div><b>Phone:</b> 800-999-6673</div><div><a href="https://rarediseases.org/for-patients-and-families/help-access-medications/patient-assistance-programs-2/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Assistance Programs</a></div></li></ul></div><div id="lal-def.Molecular_Genetics"><h2 id="_lal-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="lal-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Lysosomal Acid Lipase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK305870/table/lal-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lal-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_lal-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_lal-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_lal-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_lal-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_lal-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_lal-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_lal-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3988" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LIPA</i></a></td><td headers="hd_b_lal-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3988" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q23<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_lal-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P38571" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lysosomal acid lipase/cholesteryl ester hydrolase</a></td><td headers="hd_b_lal-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/LIPA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LIPA database</a></td><td headers="hd_b_lal-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LIPA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LIPA</a></td><td headers="hd_b_lal-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LIPA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LIPA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="lal-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="lal-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Lysosomal Acid Lipase Deficiency (<a href="/omim/278000,613497" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK305870/table/lal-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lal-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/278000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">278000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LYSOSOMAL ACID LIPASE DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613497" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613497</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LIPASE A, LYSOSOMAL ACID; LIPA</td></tr></tbody></table></div></div><div id="lal-def.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>In the normal state, the enzyme lysosomal acid lipase (LAL) degrades LDL cholesterol esters and triglycerides in lysosomes. The intracellular free cholesterol that results from the degradation of these molecules is transferred to the endoplasmic reticulum, where it interacts with transcription factors that suppress:</p><ul><li class="half_rhythm"><div>HMG-CoA reductase activity, which reduces the cellular synthesis of cholesterol;</div></li><li class="half_rhythm"><div>LDL receptor <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription, which results in reduced intracellular uptake of LDL.</div></li></ul><p>In the disease state, deficient LAL enzyme activity leads to accumulation of cholesterol esters and triglycerides within lysosomes. Less free intracellular cholesterol results in heightened synthesis of endogenous cholesterol and endocytosis via LDL receptors. The relationship between the disease state and LDL receptor <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression and activity is not entirely understood [<a class="bk_pop" href="#lal-def.REF.reiner.2014.21">Reiner et al 2014</a>]. However, the overall result of decreased LAL enzyme activity is lysosomal accumulation of cholesterol esters and triglycerides and increased levels of plasma cholesterol.</p><p><b>Gene structure.</b>
<i>LIPA</i> comprises ten exons spread across 36 kb. See <a href="/books/NBK305870/#lal-def.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> A variety of pathogenic variants have been reported to cause LAL deficiency, including <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, single- and double-nucleotide insertions and deletions, complex <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/deletions, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants [<a class="bk_pop" href="#lal-def.REF.ameis.1995.241">Ameis et al 1995</a>, <a class="bk_pop" href="#lal-def.REF.seedorf.1995.773">Seedorf et al 1995</a>, <a class="bk_pop" href="#lal-def.REF.anderson.1999.333">Anderson et al 1999</a>, <a class="bk_pop" href="#lal-def.REF.hooper.2008.152">Hooper et al 2008</a>, <a class="bk_pop" href="#lal-def.REF.pisciotta.2009.143">Pisciotta et al 2009</a>].</p><p>The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in CESD, c.894G&#x0003e;A, involves a G-to-A transition at the last base of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8 disrupting the normal donor splice consensus sequence (<a class="figpopup" href="/books/NBK305870/table/lal-def.T.selected_lipa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figlaldefTselectedlipapathogenicvaria" rid-ob="figoblaldefTselectedlipapathogenicvaria">Table 3</a>). Typically, this results in alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and subsequent skipping of exon 8. In the presence of this pathogenic variant approximately 3%-5% of transcripts are correctly spliced, allowing for residual enzyme activity.</p><div id="lal-def.T.selected_lipa_pathogenic_varia" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>LIPA</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK305870/table/lal-def.T.selected_lipa_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lal-def.T.selected_lipa_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.260G&#x0003e;T&#x000a0;<sup>2</sup></td><td headers="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly87Val<br />(Gly66Val)</td><td headers="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001127605.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001127605<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001121077.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001121077<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.894G&#x0003e;A<br />(934G&#x0003e;A)<br />(E8SJ)</td><td headers="hd_h_lal-def.T.selected_lipa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="lal-def.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="lal-def.TF.3.2"><p class="no_margin">Founder variant; see <a href="#lal-def.Prevalence">Prevalence</a>.</p></div></dd><dt>3. </dt><dd><div id="lal-def.TF.3.3"><p class="no_margin">At splice donor site of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 8, resulting in alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and subsequent skipping of exon 8</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>. The enzyme lysosomal acid lipase A is expressed in lysosomes and is responsible for the hydrolysis of cholesterol esters and triacylglycerols. It is a member of a family of highly conserved acid lipases, which also includes human gastric lipase, rat lingual lipase, and bovine pregastric lipase [<a class="bk_pop" href="#lal-def.REF.zschenker.2001.1033">Zschenker et al 2001</a>].</p><p>The catalytic active site of LAL is composed of amino acid residues Ser153, Asp324, and His353. The active-site serine is part of a lipase consensus sequence connecting a &#x003b2;-strand to an &#x003b1;-helix, known as the nucleophilic elbow, which facilitates interaction between the nucleophile and the histidine and ester carbon in the appropriately oriented complex [<a class="bk_pop" href="#lal-def.REF.lohse.1997.892">Lohse et al 1997</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Disease results from loss of function of LAL caused by <i>LIPA</i> pathogenic variants that generate truncated proteins or proteins with altered conformations or reduced activity.</p></div></div><div id="lal-def.References"><h2 id="_lal-def_References_">References</h2><div id="lal-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.abello.2010.28">Abello F, Guardamagna O, Baracco V, Bonardi R. The treatment of colesteryl storage disease (CESD) by ezetimibe monotherapy. <span><span class="ref-journal">Atheroscler Suppl. </span>2010;<span class="ref-vol">11</span>:28.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.ambler.2013.41">Ambler GK, Hoare M, Brais R, Shaw A, Butler A, Flynn P, Deegan P, Griffiths WJ. Orthotopic liver transplantation in an adult with cholesterol ester storage disease. <span><span class="ref-journal">JIMD Rep. </span>2013;<span class="ref-vol">8</span>:41–6.</span> [<a href="/pmc/articles/PMC3565644/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3565644</span></a>] [<a href="/pubmed/23430518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.ameis.1995.241">Ameis D, Brockmann G, Knoblich R, Merkel M, Ostlund RE, Yang JW, Coates PM, Cortner JA, Feinman SV, Greten H. A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesterol ester storage disease. <span><span class="ref-journal">J Lipid Res. </span>1995;<span class="ref-vol">36</span>:241–50.</span> [<a href="/pubmed/7751811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7751811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.anderson.1999.333">Anderson RA, Bryson GM, Parks JS. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. <span><span class="ref-journal">Mol Genet Metab. </span>1999;<span class="ref-vol">68</span>:333–45.</span> [<a href="/pubmed/10562460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10562460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.bernstein.2013.1230">Bernstein DL, H&#x0016f;lkov&#x000e1; H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: Review of the findings in 135 reported patients with an underdiagnosed disease. <span><span class="ref-journal">J Hepatol. </span>2013;<span class="ref-vol">58</span>:1230–43.</span> [<a href="/pubmed/23485521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23485521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.bindu.2007.1401">Bindu PS, Taly AB, Christopher R, Bharatkumar PV, Panda S, Netravathi M, Ravishankar S, Mahadevan A, Yasha TC, Gayathri N. Cholesterol ester storage disease with unusual neurological manifestations in two siblings: A report from South India. <span><span class="ref-journal">J Child Neurol. </span>2007;<span class="ref-vol">22</span>:1401–4.</span> [<a href="/pubmed/18174560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18174560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.boldrini.2004.231">Boldrini R, Devito R, Biselli R, Filocamo M, Bosman C. Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy. <span><span class="ref-journal">Pathol Res Pract. </span>2004;<span class="ref-vol">200</span>:231–40.</span> [<a href="/pubmed/15200275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15200275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.browne.2003.522">Browne M, Somers G, Savoia H, Kukuruzovic R. Wolman's disease in an infant. <span><span class="ref-journal">Br J Haematol. </span>2003;<span class="ref-vol">122</span>:522.</span> [<a href="/pubmed/12899707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12899707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.burton.2015.1010">Burton BK, Balwani M, Feillet F, Bari&#x00107; I, Burrow TA, Camarena Grande C, Coker M, Consuelo-S&#x000e1;nchez A, Deegan P, Di Rocco M, Enns GM, Erbe R, Ezgu F, Ficicioglu C, Furuya KN, Kane J, Laukaitis C, Mengel E, Neilan EG, Nightingale S, Peters H, Scarpa M, Schwab KO, Smolka V, Valayannopoulos V, Wood M, Goodman Z, Yang Y, Eckert S, Rojas-Caro S, Quinn AG. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. <span><span class="ref-journal">N Engl J Med. </span>2015;<span class="ref-vol">373</span>:1010–20.</span> [<a href="/pubmed/26352813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26352813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.chatrath.2009.168">Chatrath H, Keilin S, Attar BM. Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult. <span><span class="ref-journal">Dig Dis Sci. </span>2009;<span class="ref-vol">54</span>:168–73.</span> [<a href="/pubmed/18478331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18478331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.dalgi_.2006.148">Dalgi&#x000e7; B, Sari S, G&#x000fc;nd&#x000fc;z M, Ezg&#x000fc; F, T&#x000fc;mer L, Hasano&#x0011f;lu A, Akyol G. Cholesteryl ester storage disease in a young child presenting as isolated hepatomegaly treated with simvastatin. <span><span class="ref-journal">Turk J Pediatr. </span>2006;<span class="ref-vol">48</span>:148–51.</span> [<a href="/pubmed/16848116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16848116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.decarlis.2009.s11">Decarlis S, Agostoni C, Ferrante F, Scarlino S, Riva E, Giovannini M. Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disase. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;2009;<span class="ref-vol">32</span>:S11–3.</span> [<a href="/pubmed/19214773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19214773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.drebber.2005.2364">Drebber U, Andersen M, Kasper HU, Lohse P, Stolte M, Dienes HP. Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: A case report. <span><span class="ref-journal">World J Gastroenterol. </span>2005;<span class="ref-vol">11</span>:2364–6.</span> [<a href="/pmc/articles/PMC4305829/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4305829</span></a>] [<a href="/pubmed/15818756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15818756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.elleder.1990">Elleder M, Ledvinova J, Cieslar P, Kuhn R, (1990) Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Virchow Archiv A Pathol Anat 416:357-65. [<a href="/pubmed/2106753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2106753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.fasano.2012.450">Fasano T, Pisciotta L, Bocchi L, Guardamagna O, Assandro P, Rabacchi C, Zanoni P, Filocamo M, Bertolini S, Calandra S. Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">105</span>:450–6.</span> [<a href="/pubmed/22227072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22227072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.gasche.1997.744">Gasche C, Aslanidis C, Kain R, Exner M, Helbich T, Dejaco C, Schmitz G, Ferenci P. A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. <span><span class="ref-journal">J Hepatol. </span>1997;<span class="ref-vol">27</span>:744–50.</span> [<a href="/pubmed/9365051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9365051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.gramatges.2009.449">Gramatges MM, Dvorak C, Regula D, Enns G, Weinberg K, Agarwal R. Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity. <span><span class="ref-journal">Bone Marrow Transplant. </span>2009;<span class="ref-vol">44</span>:449–50.</span> [<a href="/pubmed/19308038" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19308038</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.hooper.2008.152">Hooper AJ, Tran HA, Formby MR, Burnett JR. A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease. <span><span class="ref-journal">Clin Chim Acta. </span>2008;<span class="ref-vol">398</span>:152–4.</span> [<a href="/pubmed/18775687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18775687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.h_lkov_.2012.1107">H&#x0016f;lkov&#x000e1; H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. <span><span class="ref-journal">Histopathology. </span>2012;<span class="ref-vol">60</span>:1107–13.</span> [<a href="/pubmed/22621222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22621222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.klima.1993.2713">Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. <span><span class="ref-journal">J Clin Invest. </span>1993;<span class="ref-vol">92</span>:2713–8.</span> [<a href="/pmc/articles/PMC288469/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC288469</span></a>] [<a href="/pubmed/8254026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8254026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.lee.2011.703">Lee TM, Welsh M, Benhamed S, Chung WK. Intragenic deletion as a novel type of mutation in Wolman disease. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">104</span>:703–5.</span> [<a href="/pmc/articles/PMC3781170/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3781170</span></a>] [<a href="/pubmed/21963785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21963785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.lohse.1997.892">Lohse P, Charhrokh-Zadeh S, Lohse P, Seidel D. Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: identification of the catalytically active serine, aspartic acid, and histidine residues. <span><span class="ref-journal">J Lipid Res. </span>1997;<span class="ref-vol">38</span>:892–903.</span> [<a href="/pubmed/9186907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9186907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.lohse.2000.23">Lohse P, Maas S, Elleder M, Kirk JM, Besley GTN, Seidel D. Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. <span><span class="ref-journal">J Lipid Res. </span>2000;<span class="ref-vol">41</span>:23–31.</span> [<a href="/pubmed/10627498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10627498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.muntoni.1995.491">Muntoni S, Wiebusch H, Funke H, Ros E, Seedorf U, Assmann G. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). <span><span class="ref-journal">Hum Genet. </span>1995;<span class="ref-vol">95</span>:491–4.</span> [<a href="/pubmed/7759067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7759067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.muntoni.2007.1866">Muntoni S, Wiebusch H, Jansen-Rust M, Rust S, Seedorf U, Schulte H, Berger K, Funke H, Assmann G. Prevalence of cholesteryl ester storage disease. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>2007;<span class="ref-vol">27</span>:1866–8.</span> [<a href="/pubmed/17634524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17634524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.nchimi.2003.284">Nchimi A, Rausin L, Khamis J. Ultrasound appearance of bowel wall in Wolman's disease. <span><span class="ref-journal">Pediatr Radiol. </span>2003;<span class="ref-vol">33</span>:284–5.</span> [<a href="/pubmed/12709765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12709765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.pagani.1996.1611">Pagani F, Garcia R, Pariyarath R, Stuani C, Gridelli B, Paone G, Baralle FE. Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease. <span><span class="ref-journal">Hum Mol Genet. </span>1996;<span class="ref-vol">5</span>:1611–7.</span> [<a href="/pubmed/8894696" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8894696</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.pisciotta.2009.143">Pisciotta L, Fresa R, Bellocchio A, Pino E, Guido V, Cantafora A, Di Rocco M, Calandra S, Bertolini S. Cholesteryl ester storage disease (CESD) due to novel mutations in the LIPA gene. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">97</span>:143–8.</span> [<a href="/pubmed/19307143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19307143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.reiner.2014.21">Reiner &#x0017d;, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S, Jones S, &#x00106;ori&#x00107; M, Calandra S, Hamilton J, Eagleton T, Ros E. Lysosomal acid lipase deficiency&#x02013;An under-recognized cause of dyslipidaemia and liver dysfunction. <span><span class="ref-journal">Atherosclerosis. </span>2014;<span class="ref-vol">235</span>:21–30.</span> [<a href="/pubmed/24792990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24792990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.riva.2008.784">Riva S, Spada M, Sciveres M, Minervini M, Cintorino D, Maggiore G, Gridelli B. Hepatocarcinoma in a child with cholesterol ester storage disease. <span><span class="ref-journal">Dig Liver Dis. </span>2008;<span class="ref-vol">40</span>:784.</span> [<a href="/pubmed/18339594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18339594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.scott.2013.958">Scott SA, Liu B, Nazarenko I, Martis S, Kozlitina J, Yang Y, Ramirez C, Kasai Y, Hyatt T, Peter I, Desnick RJ. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G&#x0003e;A) in various racial and ethnic groups. <span><span class="ref-journal">Hepatology. </span>2013;<span class="ref-vol">58</span>:958–65.</span> [<a href="/pmc/articles/PMC3690149/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3690149</span></a>] [<a href="/pubmed/23424026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23424026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.seedorf.1995.773">Seedorf U, Wiebusch H, Muntoni S, Christensen NC, Skovby F, Nickel V, Roskos M, Funke H, Ose L, Assmann G. A novel variant of lysosomal acid lipase (Leu336Pro) associated with acid lipase deficiency and cholesterol ester storage disease. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>1995;<span class="ref-vol">15</span>:773–8.</span> [<a href="/pubmed/7773732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7773732</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.shome.2002.597">Shome DK, Al-Jishi E, Greally JF, Malik N, Zainaldeen HA, Das NS. The Middle-East connection of Wolman Disease. <span><span class="ref-journal">Saudi Med J. </span>2002;<span class="ref-vol">23</span>:597–601.</span> [<a href="/pubmed/12070591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12070591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.stein.2007.663">Stein J, Garty BZ, Dror Y, Fenig E, Zeigler M, Yaniv I. Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation. <span><span class="ref-journal">Eur J Pediatr. </span>2007;<span class="ref-vol">166</span>:663–6.</span> [<a href="/pubmed/17033804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17033804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.stitziel.2013.2909">Stitziel NO, Fouchier SW, Sjouke B, Peloso GM, Moscoso AM, Auer PL, Goel A, Gigante B, Barnes TA, Melander O, Orho-Melander M, Duga S, Sivapalaratnam S, Nikpay M, Martinelli N, Girelli D, Jackson RD, Kooperberg C, Lange LA, Ardissino D, McPherson R, Farrall M, Watkins H, Reilly MP, Rader DJ, de Faire U, Schunkert H, Erdmann J, Samani NJ, Charnas L, Altshuler D, Gabriel S, Kastelein JJ, Defesche JC, Nederveen AJ, Kathiresan S, Hovingh GK. National Heart, Lung, and Blood Institute GO Exome Sequencing Project. Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. <span><span class="ref-journal">Arterioscler Thromb Vasc Biol. </span>2013;<span class="ref-vol">33</span>:2909–14.</span> [<a href="/pmc/articles/PMC4002172/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4002172</span></a>] [<a href="/pubmed/24072694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24072694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.tadiboyina.2005.26">Tadiboyina VT, Liu DM, Miskie BA, Wang J, Hegele RA. Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease. <span><span class="ref-journal">Lipids Health Dis. </span>2005;<span class="ref-vol">4</span>:26.</span> [<a href="/pmc/articles/PMC1291391/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1291391</span></a>] [<a href="/pubmed/16255772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16255772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.tolar.2009.21">Tolar J, Petryk A, Khan K, Bjoraker KJ, Jessurun J, Dolan M, Kivisto T, Charnas L, Shapiro EG, Orchard PJ. Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. <span><span class="ref-journal">Bone Marrow Transplant. </span>2009;<span class="ref-vol">43</span>:21–7.</span> [<a href="/pubmed/18776925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18776925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.valayannopoulos.2014.1135">Valayannopoulos V, Malinova V, Honz&#x000ed;k T, Balwani M, Breen C, Deegan P, Enns G, Jones S, Kane J, Stock E, Tripuraneni R, Eckert S, Schneider E, Hamilton G, Middleton M, Sirlin C, Kessler B, Bourdon C, Boyadjiev S, Sharma R, Twelves C, Whitley C, Quinn A. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. <span><span class="ref-journal">J Hepatol. </span>2014;<span class="ref-vol">61</span>:1135–42.</span> [<a href="/pmc/articles/PMC4203712/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4203712</span></a>] [<a href="/pubmed/24993530" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24993530</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.vallesayoub.2011.395">Valles-Ayoub Y, Esfandiarifard S, No D, Sinai P, Khokher Z, Kohan M, Kahen T, Darvish D. Wolman disease (LIPA p.G87V) genotype frequency in people of Iranian-Jewish ancestry. <span><span class="ref-journal">Genet Test Mol Biomarkers. </span>2011;<span class="ref-vol">15</span>:395–8.</span> [<a href="/pubmed/21291321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21291321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.vom_dahl.1999.741">vom Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau C, Vogt C, van Weely S, Aerts J, M&#x000fc;ller G, H&#x000e4;ussinger D. Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitoriosidase activity and a homozymous lysosomal acid lipase -1 exon 8 splice junction mutation. <span><span class="ref-journal">J Hepatol. </span>1999;<span class="ref-vol">31</span>:741–6.</span> [<a href="/pubmed/10551400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10551400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.yanir.2013.224">Yanir A, Allatif MA, Weintraub M, Stepensky P. Unfavorable outcome of hematopoietic stem cell transplantation in two siblings with Wolman disease due to graft failure and hepatic complications. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">109</span>:224–6.</span> [<a href="/pubmed/23583223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23583223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lal-def.REF.zschenker.2001.1033">Zschenker O, Jung N, Rethmeier J, Trautwein S, Hertel S, Zeigler M, Ameis D. Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease. <span><span class="ref-journal">J Lipid Res. </span>2001;<span class="ref-vol">42</span>:1033–40.</span> [<a href="/pubmed/11441129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11441129</span></a>]</div></li></ul></div></div><div id="lal-def.Chapter_Notes"><h2 id="_lal-def_Chapter_Notes_">Chapter Notes</h2><div id="lal-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 September 2016 (ma) Revision: enzyme replacement therapy (Management)</div></li><li class="half_rhythm"><div>30 July 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>4 October 2012 (mfm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK305870</span><span class="label">PMID: <a href="/pubmed/26225414" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26225414</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lpi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ftdp-17/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK305870&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK305870/?report=reader">PubReader</a></li><li><a href="/books/NBK305870/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK305870" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK305870" style="display:none" title="Cite this Page"><div class="bk_tt">Hoffman EP, Barr ML, Giovanni MA, et al. Lysosomal Acid Lipase Deficiency. 2015 Jul 30 [Updated 2016 Sep 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK305870/pdf/Bookshelf_NBK305870.pdf">PDF version of this page</a> (218K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#lal-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#lal-def.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#lal-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#lal-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#lal-def.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#lal-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#lal-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#lal-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#lal-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#lal-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#lal-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#lal-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3988[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LIPA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4098366" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4098366" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4098366" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4098366" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24798600" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.</a><span class="source">[Pril (Makedon Akad Nauk Umet O...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tylki-Szymańska A, Jurecka A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014; 35(1):99-106. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28197978" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.</a><span class="source">[Am J Cardiovasc Drugs. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Maciejko JJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Cardiovasc Drugs. 2017 Jun; 17(3):217-231. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23624251" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.</a><span class="source">[J Hepatol. 2013]</span><div class="brieflinkpop offscreen_noflow">Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Thelwall PE, Smith FE, Leavitt MC, Canty D, Hu W, Hollingsworth KG, Thoma C, Trenell MI, Taylor R, Rutkowski JV, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Hepatol. 2013 Sep; 59(3):543-9. Epub 2013 Apr 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301501" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sweeney WE, Avner ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24508470" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.</a><span class="source">[Gene. 2014]</span><div class="brieflinkpop offscreen_noflow">Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Civallero G, De Mari J, Bittar C, Burin M, Giugliani R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gene. 2014 Apr 10; 539(1):154-6. Epub 2014 Feb 6.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26225414" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26225414" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040e5839a66ee2ba6d7d1d">Lysosomal Acid Lipase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Lysosomal Acid Lipase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:35:20-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B30BEE03F7C2100000000080902C2&amp;ncbi_session=CE8B30BEE040E571_2057SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK305870%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK305870&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK305870/&amp;ncbi_pagename=Lysosomal Acid Lipase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B30BEE040E571_2057SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>